Screener

Eligibility screening

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in…

Sponsored by National Cancer Institute (NCI)Study detailsClinicalTrials.gov

1 US site in MD

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.